IFNA2 and breast carcinoma: To assess whether this phenomenon was exclusive of the murine cancer model, we treated human osteosarcoma (U2OS), breast carcinoma (MCF7, HMLER) and mammary epithelial (MCF10A) cell lines with recombinant human IFN-α2a and then analyzed the expression of standard human CSC markers.